Ravandi F - Search Results

1

Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.

Thomas D, O'Brien S, Faderl S, Ravandi F, Jabbour E, Pierce S, Cortes J, Kantarjian H. Thomas D, et al. Among authors: ravandi f. Cancer. 2010 Oct 1;116(19):4580-9. doi: 10.1002/cncr.25319. Cancer. 2010. PMID: 20572037 Free PMC article.

2

Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance.

Ravandi F, Cortes J, Albitar M, Arlinghaus R, Qiang Guo J, Talpaz M, Kantarjian HM. Ravandi F, et al. Br J Haematol. 1999 Dec;107(3):581-6. doi: 10.1046/j.1365-2141.1999.01736.x. Br J Haematol. 1999. PMID: 10583263 Free article.

3

Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.

Ravandi F, Rytting ME, Osmon C, Braud EL, Roach RW, Edwards K, Winn R, Abbruzzese JL, Pazdur R. Ravandi F, et al. Anticancer Drugs. 1999 Jul;10(6):519-24. doi: 10.1097/00001813-199907000-00002. Anticancer Drugs. 1999. PMID: 10885898 Clinical Trial.

4

Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia.

Ravandi F, Hayes K, Cortes J, Albitar M, Glassman A, Talpaz M, Kantarjian HM. Ravandi F, et al. Cancer. 2001 May 1;91(9):1704-8. Cancer. 2001. PMID: 11335894 No abstract available.

5

Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.

Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ, Thomas D, Cortes J, Andreeff M, Estrov Z, Rios MB, Albitar M. Ravandi F, et al. Cancer. 2001 Jun 1;91(11):1964-72. doi: 10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b. Cancer. 2001. PMID: 11391574

6

Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.

Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P, Andersson B, Claxton D, Donato M, Gajewski J, Khouri I, Korbling M, Ueno N, deVos D, Champlin R, Giralt S. Ravandi F, et al. Bone Marrow Transplant. 2001 Jun;27(12):1221-5. doi: 10.1038/sj.bmt.1703028. Bone Marrow Transplant. 2001. PMID: 11548839 Clinical Trial.

7

Cellular signalling pathways: new targets in leukaemia therapy.

Ravandi F, Talpaz M, Kantarjian H, Estrov Z. Ravandi F, et al. Br J Haematol. 2002 Jan;116(1):57-77. doi: 10.1046/j.1365-2141.2002.03236.x. Br J Haematol. 2002. PMID: 11841398 Free article. Review. No abstract available.

8

CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.

Ravandi F, Cortes J, Estrov Z, Thomas D, Giles FJ, Huh YO, Pierce S, O'Brien S, Faderl S, Kantarjian HM. Ravandi F, et al. Leuk Res. 2002 Jul;26(7):643-9. doi: 10.1016/s0145-2126(01)00188-6. Leuk Res. 2002. PMID: 12008081

9

Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.

de Lima M, Ravandi F, Shahjahan M, Andersson B, Couriel D, Donato M, Khouri I, Gajewski J, van Besien K, Champlin R, Giralt S, Kantarjian H. de Lima M, et al. Among authors: ravandi f. Cancer. 2003 Mar 1;97(5):1242-7. doi: 10.1002/cncr.11184. Cancer. 2003. PMID: 12599231 Free article. Clinical Trial.

10

New agents in acute myeloid leukemia and other myeloid disorders.

Ravandi F, Kantarjian H, Giles F, Cortes J. Ravandi F, et al. Cancer. 2004 Feb 1;100(3):441-54. doi: 10.1002/cncr.11935. Cancer. 2004. PMID: 14745859 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

830 results

Search Page